Geneos Wealth Management’s Bryn Mawr Bank Corp BMTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,000
Closed -$180K 3076
2021
Q4
$180K Hold
4,000
0.01% 915
2021
Q3
$187K Hold
4,000
0.01% 887
2021
Q2
$165K Hold
4,000
0.01% 936
2021
Q1
$183K Hold
4,000
0.01% 1005
2020
Q4
$184K Hold
4,000
0.01% 854
2020
Q3
$98K Hold
4,000
0.01% 952
2020
Q2
$104K Hold
4,000
0.01% 904
2020
Q1
$106K Sell
4,000
-30
-0.7% -$1.05K 0.01% 816
2019
Q4
$165K Hold
4,030
0.01% 769
2019
Q3
$147K Hold
4,030
0.01% 759
2019
Q2
$150K Hold
4,030
0.01% 768
2019
Q1
$145K Hold
4,030
0.01% 751
2018
Q4
$137K Hold
4,030
0.01% 732
2018
Q3
$189K Hold
4,030
0.01% 662
2018
Q2
$186K Hold
4,030
0.01% 584
2018
Q1
$177K Hold
4,030
0.02% 570
2017
Q4
$178K Buy
4,030
+30
+0.8% +$1.32K 0.02% 572
2017
Q3
$175K Hold
4,000
0.02% 551
2017
Q2
$170K Hold
4,000
0.02% 540
2017
Q1
$158K Buy
+4,000
New +$162K 0.02% 536

Geneos Wealth Management's BMTC Position: Q1 2022 in Review

Geneos Wealth Management sold out of Bryn Mawr Bank Corp (BMTC) in Q1 2022, closing a stake of 4,000 shares — an estimated $180K sold.

Geneos Wealth Management first reported a position in BMTC in Q1 2017 and held it in 20 quarters. The position peaked at $189K in Q3 2018. 0 funds tracked by Wall St. Rank hold BMTC as of Q1 2022.

  • Geneos Wealth Management reported no remaining Bryn Mawr Bank Corp position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 4,000 Bryn Mawr Bank Corp shares in Q1 2022, an estimated $180K.
  • Geneos Wealth Management first reported a position in Bryn Mawr Bank Corp in Q1 2017 and held it in 20 quarters.
  • Geneos Wealth Management's Bryn Mawr Bank Corp position peaked at $189K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Bryn Mawr Bank Corp as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.